EcoR1 Capital Fund Qualified, L.P. Insider Trading Activity

Average Profitability
14.44%
Insider Buys Quantity
8
Insider Buys Sum
$10.17M
Insider Sells Quantity
1
Insider Sells Sum
$700,128.00

Insider Activity of EcoR1 Capital Fund Qualified, L.P.

Biography of EcoR1 Capital Fund Qualified, L.P.

No biography is available at this moment.

2018-12-21PurchaseKura Oncology, Inc.
KURA
10 percent owner
167,080
0.4716%
$13.16$2.2M+18.49%
2018-12-19PurchaseKura Oncology, Inc.
KURA
10 percent owner
103,758
0.2915%
$13.84$1.44M+12.11%
2018-12-18PurchaseKura Oncology, Inc.
KURA
10 percent owner
156,938
0.4434%
$13.82$2.17M+12.91%
2018-12-17SaleKura Oncology, Inc.
KURA
10 percent owner
53,040
0.1507%
$13.20$700,128+18.9%
2018-12-13PurchaseKura Oncology, Inc.
KURA
10 percent owner
50,434
0.1437%
$13.89$700,528+13.32%
2018-12-11PurchaseKura Oncology, Inc.
KURA
10 percent owner
30,642
0.0864%
$13.91$426,197+11.95%
2018-12-06PurchaseKura Oncology, Inc.
KURA
10 percent owner
34,158
0.0963%
$13.49$460,791+15.15%
2018-12-04PurchaseKura Oncology, Inc.
KURA
10 percent owner
109,290
0.3106%
$13.08$1.43M+19.95%
2018-12-03PurchaseKura Oncology, Inc.
KURA
10 percent owner
96,364
0.2723%
$13.97$1.35M+11.67%
2017-11-13SaleaTyr Pharma, Inc.
ATYR
10 percent owner
1,083
0.0059%
$3.95$4,278
2017-11-10SaleaTyr Pharma, Inc.
ATYR
10 percent owner
5,860
0.0324%
$4.00$23,445
2017-11-09SaleaTyr Pharma, Inc.
ATYR
10 percent owner
5,819
0.0334%
$4.15$24,151
2017-11-08SaleaTyr Pharma, Inc.
ATYR
10 percent owner
1,070
0.0064%
$4.30$4,601
2017-11-01PurchaseaTyr Pharma, Inc.
ATYR
10 percent owner
24,728
0.1642%
$4.80$118,694
2017-10-01PurchaseaTyr Pharma, Inc.
ATYR
10 percent owner
4,879
0.0341%
$5.05$24,639
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.